Alpha 2.0
Login Register
» Authors » Karel Labr

Karel Labr

Explore the profile of Karel Labr including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 32
Followers 0
Related Specialties
General Medicine
Science
Endocrinology
Top 10 Co-Authors
Lenka Spinarova
Monika Spinarova
Filip Malek
Jindrich Spinar
Ondrej Ludka
Jiri Parenica
Jiri Jarkovsky
Klara Benesova
Petr Ostadal
Jan Krejci
Published In
PLoS One
Kidney Blood Press Res
Medicina (Kaunas)
Vnitr Lek
Bratisl Lek Listy
Affiliations
Soon will be listed here.
Recent Articles
1.
Diabetes mellitus in stable chronic heart failure and the combination with humoral activation, their association, and prediction of 2-year adverse outcomes. Data from the FAR NHL registry
Labr K, Spinar J, Parenica J, Spinarova L, Krejci J, Malek F, et al.
J Diabetes . 2024 Sep; 16(9):e13605. PMID: 39263998
Background/aim: The study aims to describe the role of diabetes in patients with heart failure. Methods: In all, 1052 chronic heart failure patients were included in the FARmacology and NeuroHumoral...
2.
Effect of selected cardiovascular factors on mortality in patients with ST-segment elevation myocardial infarction treated with primary coronary intervention
Komorova Z, Machal J, Groch L, Spinarova L, Labr K
Bratisl Lek Listy . 2023 Mar; 124(6):421-426. PMID: 36876376
Objective: This work was aimed at analyzing in-hospital, 30-day and 1-year mortality rates, impact of selected cardiovascular factors on mortality of patients with ST-segment elevation myocardial infarction (STEMI) manifested on...
3.
Relation between Mid-Regional Pro-Adrenomedullin in Patients with Chronic Heart Failure and the Dose of Diuretics in 2-Year Follow-Up-Data from FAR NHL Registry
Spinarova M, Spinar J, Spinarova L, Krejci J, Goldbergova-Pavkova M, Parenica J, et al.
Medicina (Kaunas) . 2022 Oct; 58(10). PMID: 36295637
Background and Objectives: The aim of this paper is to evaluate the impact of humoral substance mid-regional pro-adrenomedullin (MR-proADM) on the two-year survival of patients with chronic heart failure and...
4.
Prognostic value of high-sensitivity cardiac troponin I in heart failure patients with mid-range and reduced ejection fraction
Lokaj P, Spinar J, Spinarova L, Malek F, Ludka O, Krejci J, et al.
PLoS One . 2021 Jul; 16(7):e0255271. PMID: 34329368
Background: The identification of high-risk heart failure (HF) patients makes it possible to intensify their treatment. Our aim was to determine the prognostic value of a newly developed, high-sensitivity troponin...
5.
Prognostic value of NT-proBNP added to clinical parameters to predict two-year prognosis of chronic heart failure patients with mid-range and reduced ejection fraction - A report from FAR NHL prospective registry
Spinar J, Spinarova L, Malek F, Ludka O, Krejci J, Ostadal P, et al.
PLoS One . 2019 Mar; 14(3):e0214363. PMID: 30913251
Background: According to guidelines, the prognosis of patients with chronic heart failure can be predicted by determining the levels of natriuretic peptides, the NYHA classification and comorbidities. The aim our...
6.
Prescription and dosage of RAAS inhibitors in patients with chronic heart failure in the FAR NHL registry
Spinarova M, Spinar J, Parenica J, Spinarova L, Malek F, Labr K, et al.
Vnitr Lek . 2019 Mar; 65(1):13-14. PMID: 30823832
Background: Congestive heart failure with reduced ejection fraction is a common clinical condition with a serious prognosis. Treatment focuses on improving the symptoms and preventing the progression of the disease....
7.
Renal Functions and Prognosis Stratification in Chronic Heart Failure Patients and the Importance of Neutrophil Gelatinase-Associated Lipocalin
Labr K, Spinar J, Parenica J, Spinarova L, Malek F, Spinarova M, et al.
Kidney Blood Press Res . 2018 Dec; 43(6):1865-1877. PMID: 30537724
Background/aims: The rate of incidence and prevalence of acute kidney injury is increasing due to an increased number of patients with heart failure. Therefore it is very pertinent to early...